durvalumab - imfinzi - all you need to know in 2 minutes.
Published 2 months ago • 333 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
3:48
poseidon: durvalumab /- tremelimumab chemo in 1l mnsclc
-
8:16
case based panel discussion - stage 3 nsclc best schedule - durvalumab/imfinzi in varying patients
-
8:28
imfinzi uses: guide to understanding the many benefits of this breakthrough immunotherapy
-
2:26
durvalumab following chemoradiotherapy and surgery
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
2:12
safir 02: durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer
-
8:35
microwave ablation of the liver | ucla health
-
15:05
3 things you need during chemo
-
8:10
iaslc 2024 world conference on lung cancer: dr. halmos on harmoni-2, tropion-lung-01, and more
-
2:56
durvalumab after chemoradiotherapy improves overall survival in lung cancer patients
-
3:07
the use of durvalumab in locally advanced nsclc
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
1:37
results for durvalumab in the second-line treatment of nsclc
-
3:22
locally advanced nsclc: durvalumab and the pacific trial
-
6:06
stage iii nsclc: when to start durvalumab
-
8:57
mermaid-2: phase 3 study of durvalumab in patients with resected stage mrd ii-iii nsclc
-
8:36
pacific trial: durvalumab for stage 3 nsclc
-
1:20
dr. simon on durvalumab for patients with lung cancer
-
6:38
pacific trial of durvalumab for lung cancer